User contributions for Palmdoc
From OncoWiki
Jump to navigationJump to search
27 August 2018
- 05:2205:22, 27 August 2018 diff hist +1,614 SMILE No edit summary current
- 01:4401:44, 27 August 2018 diff hist +10 m Lymphoma Hodgkin's, Adult →Frontline current
14 June 2017
- 13:0613:06, 14 June 2017 diff hist +931 N BeGeV Created page with "== Hodgkin disease == salvage regimen in relapsed Hodgkin's lymphoma == Regimen == phase II study * Gemcitabine 800 mg/m2 on days 1 and 4 * Vinorelbine 20 mg/m2 on day 1, *..." current
- 12:5712:57, 14 June 2017 diff hist +14 Lymphoma Hodgkin's, Adult →Salvage
21 September 2016
- 02:0302:03, 21 September 2016 diff hist +593 Flu Bu ATG - Slavin No edit summary current
- 02:0202:02, 21 September 2016 diff hist +316 N Flu Bu ATG - Slavin Created page with "*Fludarabine (Fludara) 30 mg/m<sup>2</sup> IV once per day on days -10 to -5 (6 consecutive days) *Busulfan (Myleran) 4 mg/kg/day PO on days -6 to -5 (2 consecutive da..."
- 01:5501:55, 21 September 2016 diff hist +1 m Stem Cell Transplantation →Non-myeloablative conditioning regimens current
- 01:5401:54, 21 September 2016 diff hist +23 Stem Cell Transplantation →Non-myeloablative conditioning regimens
6 July 2016
- 20:2120:21, 6 July 2016 diff hist +2,303 N Flu Bu ATG for Haplo Created page with "== Regimen == *Busulfan (Busulfex, Otsuka Pharmaceuticals) 3.2 mg/kg per day intravenously on days −7 and −6 *Fludarabine 30 mg/m2 per day intravenously on days −7 to..." current
- 20:0720:07, 6 July 2016 diff hist +1 m Stem Cell Transplantation →Non-myeloablative conditioning regimens
- 20:0620:06, 6 July 2016 diff hist +25 Stem Cell Transplantation →Non-myeloablative conditioning regimens
16 May 2016
- 21:5221:52, 16 May 2016 diff hist +1,666 N R-MPV Created page with "== Regimen == IV Rituximab 500 mg/m2 day 1 IV Methotrexate 3.5 mg/m2 (over 2hours) day 2 IV Vincristine 1.4 mg/m2 (capped at 2.8mg)day 2 Procarbazine 100 mg/m2 /day was gi..." current
- 21:4521:45, 16 May 2016 diff hist +4 m Lymphoma Non-Hodgkin's, Adult →Primary CNS Lymphoma current
- 21:4421:44, 16 May 2016 diff hist +10 Lymphoma Non-Hodgkin's, Adult →Primary CNS Lymphoma
18 April 2016
- 02:1802:18, 18 April 2016 diff hist +1,734 N VDT-PACE VDTPACE current
- 01:5001:50, 18 April 2016 diff hist +1 m Multiple Myeloma And Plasma Cell Dyscrasias →Combinations current
- 01:5001:50, 18 April 2016 diff hist +13 m Multiple Myeloma And Plasma Cell Dyscrasias No edit summary
1 May 2014
- 22:0122:01, 1 May 2014 diff hist +35 m Lymphoma Non-Hodgkin's, Adult →Aggressive NHL
- 21:5421:54, 1 May 2014 diff hist +113 m Brentuximab vedotin →Brentuximab vedotin (Adcetris) current
- 21:5321:53, 1 May 2014 diff hist +1,048 m Brentuximab vedotin →Regimen
- 21:5021:50, 1 May 2014 diff hist +334 N Brentuximab vedotin Created page with "==Brentuximab vedotin (Adcetris)== ===Regimen=== *Brentuximab vedotin (Adcetris) 1.8 mg/kg IV over 30 minutes on day 1 Supportive medications: *Rothe et al. 2012: "no p..."
- 21:4921:49, 1 May 2014 diff hist +28 m Lymphoma Hodgkin's, Adult →Salvage
30 October 2013
- 03:3603:36, 30 October 2013 diff hist −25 m Adrenocortical Carcinoma No edit summary current
- 03:3503:35, 30 October 2013 diff hist +25 m Adrenocortical Carcinoma No edit summary
- 03:1603:16, 30 October 2013 diff hist +52 m Adrenocortical Carcinoma →References
- 03:1303:13, 30 October 2013 diff hist −61 m Adrenocortical Carcinoma →References
- 03:1203:12, 30 October 2013 diff hist +127 m Adrenocortical Carcinoma →References
- 03:1003:10, 30 October 2013 diff hist +879 m Adrenocortical Carcinoma →References
- 03:0703:07, 30 October 2013 diff hist +344 m Adrenocortical Carcinoma No edit summary
- 03:0103:01, 30 October 2013 diff hist +128 m Adrenocortical Carcinoma No edit summary
- 02:4402:44, 30 October 2013 diff hist +822 Adrenocortical Carcinoma →Adrenal gland tumors, adrenocortical carcinoma - adjuvant therapy
- 02:4302:43, 30 October 2013 diff hist +803 m Adrenocortical Carcinoma →Adrenal gland tumors, adrenocortical carcinoma - adjuvant therapy
- 02:4102:41, 30 October 2013 diff hist +67 N Adrenocortical Carcinoma Created page with "=Adrenal gland tumors, adrenocortical carcinoma - adjuvant therapy="
- 02:3402:34, 30 October 2013 diff hist +642 N OncoWiki:General disclaimer Created page with "Information on this website is meant only for Healthcare Practitioners. Use of any information obtained from this website is entirely at the user's discretion. You are advised..." current
- 02:3402:34, 30 October 2013 diff hist +192 N OncoWiki:About Created page with "This site will serve as a free repository for oncology information, chemotherapy protocols and cancer treatment regimens and is meant for Healthcare providers working in the f..." current
26 October 2013
- 09:4609:46, 26 October 2013 diff hist +26 Main Page No edit summary current
29 August 2013
- 07:2807:28, 29 August 2013 diff hist +5 m EPOCH-DA →References current
- 07:2107:21, 29 August 2013 diff hist +759 m EPOCH-DA No edit summary
- 07:2007:20, 29 August 2013 diff hist +20 m EPOCH-DA →Dose adjustments
- 07:1907:19, 29 August 2013 diff hist +405 m EPOCH-DA No edit summary
- 07:1807:18, 29 August 2013 diff hist +5 m EPOCH-DA →Supportive medications
- 07:1607:16, 29 August 2013 diff hist +5 m EPOCH-DA →Supportive medications
- 07:1607:16, 29 August 2013 diff hist +117 m EPOCH-DA →Supportive medications
- 07:1507:15, 29 August 2013 diff hist +113 m EPOCH-DA →Supportive medications
- 07:1507:15, 29 August 2013 diff hist +31 EPOCH-DA →Regimen
- 07:1407:14, 29 August 2013 diff hist +32 m EPOCH-DA →Regimen
- 07:1407:14, 29 August 2013 diff hist +169 m EPOCH-DA →Regimen
- 07:1307:13, 29 August 2013 diff hist +114 m EPOCH-DA →Regimen
- 07:0507:05, 29 August 2013 diff hist +45 m EPOCH-DA →Regimen
- 07:0407:04, 29 August 2013 diff hist +110 m EPOCH-DA →Regimen
- 07:0307:03, 29 August 2013 diff hist +82 m EPOCH-DA →Regimen
- 07:0207:02, 29 August 2013 diff hist +45 N EPOCH-DA Created page with "== Regimen == R-EPOCH-DA: Dose Adjusted EPOCH"
- 06:5306:53, 29 August 2013 diff hist +17 Lymphoma Non-Hodgkin's, Adult →Aggressive NHL
16 August 2013
- 09:3109:31, 16 August 2013 diff hist +1 Clofarabine, cyclophosphamide and etoposide →Regimen current
9 October 2012
- 03:5803:58, 9 October 2012 diff hist +66 Acute Myeloid Leukemia,Adult →Post-remission regimens current
- 03:5703:57, 9 October 2012 diff hist +47 Acute Myeloid Leukemia,Adult →Induction regimens
- 03:5703:57, 9 October 2012 diff hist +1,430 N Cytarabine Idarubicin Vorinostat induction Created page with "==Cytarabine (Cytosar), Idarubicin (Idamycin), Vorinostat (Zolinza) induction== ===Regimen=== *Vorinostat (Zolinza) 500 mg PO TID on days 1-3 *Cytarabine (Cytosar) 150..." current
- 03:5603:56, 9 October 2012 diff hist +1,281 N Cytarabine Idarubicin Vorinostat consolidation Created page with "==Cytarabine (Cytosar), Idarubicin (Idamycin), Vorinostat (Zolinza) consolidation== Preceded by Cytarabine_Idarubicin_Vorinostat_induction therapy. ===Regimen=== *[[Vorin..." current
- 03:5503:55, 9 October 2012 diff hist −116 m Vorinostat →Vorinostat (Zolinza) maintenance current
- 03:5303:53, 9 October 2012 diff hist +938 N Vorinostat Created page with "==Vorinostat (Zolinza) maintenance== Preceded by [[#Cytarabine_.28Cytosar.29.2C_Idarubicin_.28Idamycin.29.2C_Vorinostat_.28Zolinza.29_consolidation|Cytarabine (Cytosar), Idaru..."
- 03:5303:53, 9 October 2012 diff hist +19 Acute Myeloid Leukemia,Adult →Post-remission regimens
8 October 2012
- 03:0203:02, 8 October 2012 diff hist −50 m BEAC →Regimen current
- 03:0203:02, 8 October 2012 diff hist +1,121 N BEAC Created page with "BEAC: '''<u>B</u>'''iCNU, '''<u>E</u>'''toposide, '''<u>A</u>'''ra-C, '''<u>C</u>'''yclophosphamide ===Regimen === ''Autologous blood stem cells are infused on day 0.'' *[[Car..."
- 02:4902:49, 8 October 2012 diff hist +2,934 BEAM →Regimen current
- 02:0002:00, 8 October 2012 diff hist +107 m BEAM →Regimen
- 01:5201:52, 8 October 2012 diff hist −2 m BEAM →Regimen
- 01:4801:48, 8 October 2012 diff hist +1,010 N BEAM Created page with "===Regimen=== ''Day 0 is the day of transplantation.'' *Carmustine 300 mg/m2 IV on day -6 *Etoposide ) 200 mg/m2 IV BID on days -5 to -2 *Cytarabine ) 200 mg/m2 I..."
- 01:4601:46, 8 October 2012 diff hist +4 m Stem Cell Transplantation →Autograft regimens
- 01:4601:46, 8 October 2012 diff hist +19 Stem Cell Transplantation →Autograft regimens
- 01:3901:39, 8 October 2012 diff hist +33 Cytotoxic Regimens →External Links current
30 September 2012
- 03:4103:41, 30 September 2012 diff hist +47 m Main Page →Editors
27 August 2012
- 08:2708:27, 27 August 2012 diff hist +4 APL4 - ALLG →References current
- 08:2408:24, 27 August 2012 diff hist +4 m APL4 - ALLG →References
- 08:2408:24, 27 August 2012 diff hist +3,041 N APL4 - ALLG Created page with "== Regimen == '''Induction''' ATRA 45mg/m2/d PO Days 1-36 in divided doses Idarubicin 12mg/m2/d IV(ages 1-60) Days 2,4,6,and 8 9mg/m2/d IV (ages 61-70) 6mg/m2/d IV (ag..."
- 08:2308:23, 27 August 2012 diff hist 0 Acute Myeloid Leukemia,Adult →APL Regimens
- 08:1008:10, 27 August 2012 diff hist +20 Acute Myeloid Leukemia,Adult →APL Regimens
26 May 2012
- 23:3023:30, 26 May 2012 diff hist −1 m CLAG-M No edit summary current
- 23:2923:29, 26 May 2012 diff hist +443 ATRA plus As203 No edit summary current
- 23:2523:25, 26 May 2012 diff hist +4 m CLAG-M No edit summary
- 23:2423:24, 26 May 2012 diff hist +5 CLAG-M No edit summary
- 23:2423:24, 26 May 2012 diff hist +969 N CLAG-M Created page with "== Indication == Relapsed or refractory acute myeloid leukemia == Regimen == *Cladribine (2-CdA) 5 mg/m2/d iv over 2 hrs d1-5 *Cytarabine (Ara-C) 2 g/m2/d iv over 4 hrs star..."
- 23:2223:22, 26 May 2012 diff hist 0 m Acute Myeloid Leukemia,Adult →Salvage Regimens
- 23:2123:21, 26 May 2012 diff hist +4 m Acute Myeloid Leukemia,Adult →Salvage Regimens
- 23:2123:21, 26 May 2012 diff hist +11 Acute Myeloid Leukemia,Adult →Salvage Regimens
26 February 2012
- 10:0110:01, 26 February 2012 diff hist +65 FOLFIRINOX No edit summary current
- 10:0010:00, 26 February 2012 diff hist +1,094 FOLFIRINOX No edit summary
- 09:5809:58, 26 February 2012 diff hist +38 N FOLFIRINOX Created page with "== Metastatic Pancreatic Cancer =="
- 09:5709:57, 26 February 2012 diff hist +16 Pancreatic Cancer No edit summary current
23 February 2012
- 05:1505:15, 23 February 2012 diff hist −241 m VMP →Multiple Myeloma current
- 05:1405:14, 23 February 2012 diff hist +483 N VMP Created page with "== Multiple Myeloma == Bortezomib 1.3 mg/m2 IV or SC. Given subcutaneously or as a rapid IV bolus over three to five seconds. Days 1, 8, 15, and 22 Melphalan 9 mg/m2 PO dai..."
- 05:0805:08, 23 February 2012 diff hist +12 Multiple Myeloma And Plasma Cell Dyscrasias →Bortezomib regimens
20 February 2012
- 23:5923:59, 20 February 2012 diff hist +591 Cyclophosphamide Bortezomib Dexamethasone →Reference current
- 23:5523:55, 20 February 2012 diff hist +10 m Multiple Myeloma And Plasma Cell Dyscrasias →Bortezomib regimens
- 23:5423:54, 20 February 2012 diff hist +359 Cyclophosphamide Bortezomib Dexamethasone No edit summary
12 February 2012
- 21:4321:43, 12 February 2012 diff hist +10 MediaWiki:Sidebar No edit summary current
- 21:4121:41, 12 February 2012 diff hist −8 MediaWiki:Sidebar No edit summary
- 21:3921:39, 12 February 2012 diff hist −514 Main Page No edit summary
- 14:0414:04, 12 February 2012 diff hist 0 m Talk:Main Page Protected "Talk:Main Page" ([edit=sysop] (indefinite) [move=sysop] (indefinite)) current
- 14:0414:04, 12 February 2012 diff hist 0 m Main Page Protected "Main Page" ([edit=sysop] (indefinite) [move=sysop] (indefinite))
11 February 2012
- 10:3010:30, 11 February 2012 diff hist +176 N MediaWiki:Common.css Created page with "→CSS placed here will be applied to all skins: →Pad Google AdSense box in portlet in sidebar: #p-googleadsense .pBody { padding-top: 5px; text-align: center; }" current
- 10:1010:10, 11 February 2012 diff hist +7 m MediaWiki:Sidebar No edit summary
- 10:0910:09, 11 February 2012 diff hist +217 N MediaWiki:Sidebar Created page with " * navigation ** mainpage|mainpage-description // ** portal-url|portal ** currentevents-url|currentevents ** recentchanges-url|recentchanges ** randompage-url|randompage ** he..."
10 February 2012
- 22:0222:02, 10 February 2012 diff hist +1,382 m Main Page →Editors
7 February 2012
- 02:5902:59, 7 February 2012 diff hist −236 m Main Page →Welcome to Onco Wiki
- 02:3102:31, 7 February 2012 diff hist +336 N Weekly Carboplatin + Paclitaxel + RT → Carboplatin + Paclitaxel Created page with "== Indication == Concurrent chemoradiation for stage III cancer *Paclitaxel (Taxol) 45-50 mg/m2 iv over 1 h qw x 7 weeks *Carboplatin ACU 2 iv over 30 min qw x 7 weeks *Radio..." current
- 02:3102:31, 7 February 2012 diff hist +354 N Cisplatin + Etoposide + RT → Docetaxel Created page with "== Indication == Concurrent chemoradiation for stage III cancer *Cisplatin 50 mg/m2 iv days 1, 8, 29 and 36 *Etoposide (VP-16) 50 mg/2 iv days 1-5, 29-33 *Radiotherapy 1.8 Gy..." current
- 02:3002:30, 7 February 2012 diff hist −5 m Cancer treatment information No edit summary current
- 02:2702:27, 7 February 2012 diff hist −162 m Main Page No edit summary
- 02:2002:20, 7 February 2012 diff hist −2,993 Talk:Main Page Blanked the page
- 02:1902:19, 7 February 2012 diff hist +124 Guidelines for contributors No edit summary current
- 02:1802:18, 7 February 2012 diff hist −5 m Cytotoxic Regimens →Sections
- 02:1802:18, 7 February 2012 diff hist 0 m XELOX + Bevacizumab 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m XELIRI + Bevacizumab 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Vinorelbine 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m VeIP 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m VNCOP-B 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m VMPT 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m VIP 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m VAD 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Unknown Primary, Carcinoma Of 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m TrophoblasticTumors, Gestational 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Total Therapy 2 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Total Therapy 1 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Topotecan 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Thymoma And Thymic Carcinoma 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Thal/Dex 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Testicular Cancer 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Test spam 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Temsirolimus 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Temozolomide + Thalidomide 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Temozolomide + RT 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Temozolomide + IL-2 + IFN + GM-CSF 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Temozolomide + IFN 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Temozolomide 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Tamoxifen 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m TIP 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Sunitinib 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Streptozocin + Doxorubicin 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Streptozocin + 5-FU 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Stem Cell Transplantation 1 revision
- 02:1802:18, 7 February 2012 diff hist 0 m Stanford V 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Standard BEACOPP 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Standard3plus7 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Sorafenib 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Satraplatin + Prednisone 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Sarcoma 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Sandbox 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m SMILE 1 revision
- 02:1802:18, 7 February 2012 diff hist 0 m Rituximab, Bendamustine, Bortezomib 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Rituximab 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Rev/Dex 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m RTOG study 93-10 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m RICE 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m RC 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m R-MCP 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m R-GemOx 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m R-FCM + maintenance R 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m R-FCM 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m R-EPOCH 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m R-CVP 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m R-CHOP 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Prostate Cancer 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Prednisone 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Postremission High Dose Cytarabine 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Plerixafor and G-CSF 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Pentostatin 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Pemetrexed 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Pegylated liposomal doxorubicin 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Panitumumab 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Pancreatic Cancer 1 revision
- 02:1802:18, 7 February 2012 diff hist 0 m Paclitaxel IV + Cisplatin IP + Paclitaxel IP 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Paclitaxel + Gemcitabine 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Paclitaxel + Carboplatin + Gemcitabine 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Paclitaxel 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m PCV 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m PCR 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m PAD 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m PAC 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Oxaliplatin + Capecitabine 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Ovarian Epithelial Cancer 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Octreotide 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Oblimersen + Dacarbazine 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Non-Hematological Malignancies 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Nilotinib 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Nasopharyngeal Cancer 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Myelodysplastic Syndromes 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Multiple Myeloma And Plasma Cell Dyscrasias 1 revision
- 02:1802:18, 7 February 2012 diff hist 0 m Mitoxantrone + Prednisone 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Mini-BEAM 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m MiCMA 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Melanoma 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Megestrol acetate 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Malignant Mesothelioma 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Main Page 1 revision
- 02:1802:18, 7 February 2012 diff hist 0 m MVAC 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m MRC UKALL XII/ECOG E2993 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m MPT 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m MP 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m MOPPABV Hybrid 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m MOPP 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m MINE/ESHAP 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m MIME 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m MCP 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m MAID 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m MACOP-B 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m M-BACOD 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Lymphoma Non-Hodgkin's, Adult 1 revision
- 02:1802:18, 7 February 2012 diff hist 0 m Lymphoma Hodgkin's, Adult 1 revision
- 02:1802:18, 7 February 2012 diff hist 0 m Luprolide 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Lung Cancer Small Cell 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Lung Cancer Non Small Cell 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Linker Regimen 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Lenalidomide + Rituximab 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Lenalidomide 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m LV + 5-FU + Irinotecan + Bevacizumab 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m LV5FU-P 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m LALA 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Kidney Renal Cell Cancer 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Ketoconazole 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Kaposi's Sarcoma 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Imatinib 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Ifosfamide + Paclitaxel 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Ifosfamide 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m IVE 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m IMVP-16 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m IL-2 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m IFL + Bevacizumab 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m ICE-aml 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m ICE 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m HyperCVADHDMTX-AraC 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m HyperCVAD 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m High dose Methotrexate 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Hepatocellular Cancer Adult, Primary 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Hematological Malignancies 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Hairy Cell Leukemia 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m HAM 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Guidelines on using this site 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Guidelines for contributors 1 revision
- 02:1802:18, 7 February 2012 diff hist 0 m Goserelin + Flutamide + RT 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Goserelin 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Gemtuzumab Ozogamicin 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Gemcitabine + Vinorelbine 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Gemcitabine + Paclitaxel 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Gemcitabine + Oxaliplatin 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Gemcitabine + Erlotinib 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Gemcitabine + Docetaxel 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Gemcitabine + Cisplatin + Paclitaxel 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Gemcitabine + Cisplatin 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Gemcitabine + Capecitabine 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Gemcitabine + 5-FU + RT 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Gemcitabine 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Gefitinib 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Gastric Cancer 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m GVD 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m GEM-Vinorelbine-Pred 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m GEM-P 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Fotemustine 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Flutamide 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Fludarabine + Rituximab 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Fludarabine + Prednisone 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Fludarabine 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m FUFOX + Cetuximab 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m FP + Surgery +/- FP 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m FOLFOX6 + Bevacizumab 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m FOLFOX6 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m FOLFOX4 + Cetuximab 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m FOLFOX4 + Bevacizumab 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m FOLFOX4 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m FOLFOX 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m FOLFIRI + Cetuximab 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m FOLFIRI + Bevacizumab 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m FND 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m FN 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m FLOX 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m FLOFOXIRI 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m FLAG-Ida 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m FLAG 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m FCR 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m FCM 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m FC 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Ewing’s sarcoma and primitive neuroectodermal tumor of bone 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Etoposide + Cisplatin 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Etoposide 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Esophageal Cancer 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Escalated BEACOPP 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Erlotinib 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Endometrial Cancer 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m EVAP 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m EVA 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m ESHAP 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m EPOCH 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m EPIC 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m EP 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m ECF + surgery + ECF 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m ECF 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m EBVMm 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m EAPLG 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Doxorubicin + Bleomycin + Vinblastine 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Doxorubicin 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Docetaxel + Prednisone 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Docetaxel + Estramustine 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Docetaxel 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Dexamethosone 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Dexamethasone 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Dexa-BEAM 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Decitabine 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m DaunoXome 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Dasatinib 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Dactinomycin 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Dacarbazine + Cisplatin + Carmustine 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Dacarbazine 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m DVD 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m DT-PACE 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m DHAX 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m DHAP 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m DAT 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Cytotoxic Regimens 1 revision
- 02:1802:18, 7 February 2012 diff hist 0 m Cyclophosphamide Bortezomib Dexamethasone 1 revision
- 02:1802:18, 7 February 2012 diff hist 0 m Cyclophosphamide 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Current events 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Colon Cancer 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Clofarabine, cyclophosphamide and etoposide 1 revision
- 02:1802:18, 7 February 2012 diff hist 0 m Cladribine 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Cisplatin + Vinorelbine 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Cisplatin + Topotecan 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Cisplatin + RT 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Cisplatin + Pemetrexed 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Cisplatin + Paclitaxel 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Cisplatin + Irinotecan + Bevacizumab 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Cisplatin + Irinotecan 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Cisplatin + Gemcitabine + Bevacizumab 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Cisplatin + Gemcitabine 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Cisplatin + Etoposide or Vinorelbine or Vinblastine or Vindesine 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Cisplatin + Etoposide + RT 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Cisplatin + Etoposide + Bleomycin 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Cisplatin + Etoposide 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Cisplatin + Epirubicin + 5-FU 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Cisplatin + Epirubicin 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Cisplatin + Docetaxel 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Cisplatin + Capecitabine 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Cisplatin + 5-FU + RT 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Cisplatin + 5-FU 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Cisplatin 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Chronic Myelogenous Leukemia 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Chronic Lymphocytic Leukemia 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Chlorambucil + Prednisone 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Chlorambucil 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m ChlVPP 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Cetuximab + Irinotecan 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Cetuximab 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Cervical Cancer 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Carmustine 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Carcinoid Tumors, Gastrointestinal 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Carboplatin + Vinorelbine 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Carboplatin + Pemetrexed 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Carboplatin + Paclitaxel + Etoposide 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Carboplatin + Paclitaxel + Bevacizumab 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Carboplatin + Paclitaxel 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Carboplatin + Irinotecan 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Carboplatin + Gemcitabine 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Carboplatin + Etoposide 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Carboplatin + Docetaxel 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Carboplatin 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Capecitabine + RT 1 revision current
- 02:1702:17, 7 February 2012 diff hist 0 m Capecitabine 1 revision current
- 02:1702:17, 7 February 2012 diff hist 0 m CapIri 1 revision current
- 02:1702:17, 7 February 2012 diff hist 0 m Cancer treatment information 1 revision
- 02:1702:17, 7 February 2012 diff hist 0 m CVP 1 revision current
- 02:1702:17, 7 February 2012 diff hist 0 m CVD + IL-2 + IFN 1 revision current
- 02:1702:17, 7 February 2012 diff hist 0 m CVD 1 revision current
- 02:1702:17, 7 February 2012 diff hist 0 m COPP 1 revision current
- 02:1702:17, 7 February 2012 diff hist 0 m CODOX-M/IVAC 1 revision current
- 02:1702:17, 7 February 2012 diff hist 0 m CNOP 1 revision current
- 02:1702:17, 7 February 2012 diff hist 0 m CMV 1 revision current
- 02:1702:17, 7 February 2012 diff hist 0 m CMF 1 revision current
- 02:1702:17, 7 February 2012 diff hist 0 m CLAG 1 revision current
- 02:1702:17, 7 February 2012 diff hist 0 m CIM 1 revision current
- 02:1702:17, 7 February 2012 diff hist 0 m CHOP-14 1 revision current
- 02:1702:17, 7 February 2012 diff hist 0 m CHOP 1 revision current
- 02:1702:17, 7 February 2012 diff hist 0 m CHOEP-14 1 revision current
- 02:1702:17, 7 February 2012 diff hist 0 m CFAR 1 revision current
- 02:1702:17, 7 February 2012 diff hist 0 m CEP 1 revision current
- 02:1702:17, 7 February 2012 diff hist 0 m CEOP 1 revision current
- 02:1702:17, 7 February 2012 diff hist 0 m CBI 1 revision current
- 02:1702:17, 7 February 2012 diff hist 0 m CB 1 revision current
- 02:1702:17, 7 February 2012 diff hist 0 m CALGB 9710 1 revision current
- 02:1702:17, 7 February 2012 diff hist 0 m CALGB 9111 1 revision current
- 02:1702:17, 7 February 2012 diff hist 0 m CALGB 8811 1 revision current
- 02:1702:17, 7 February 2012 diff hist 0 m CAF 1 revision current
- 02:1702:17, 7 February 2012 diff hist 0 m Breast Cancer 1 revision current
- 02:1702:17, 7 February 2012 diff hist 0 m Brain Tumors Adult 1 revision current
- 02:1702:17, 7 February 2012 diff hist 0 m Bortezomib 1 revision current
- 02:1702:17, 7 February 2012 diff hist 0 m Bonn protocol 1 revision current
- 02:1702:17, 7 February 2012 diff hist 0 m Bladder Cancer 1 revision current
- 02:1702:17, 7 February 2012 diff hist 0 m Bile Duct Cancer Extrahepatic 1 revision current
- 02:1702:17, 7 February 2012 diff hist 0 m Bicalutamide 1 revision current
- 02:1702:17, 7 February 2012 diff hist 0 m BiRD 1 revision current
- 02:1702:17, 7 February 2012 diff hist 0 m Bevacizumab + IFN 1 revision current
- 02:1702:17, 7 February 2012 diff hist 0 m Bevacizumab + Erlotinib 1 revision current
- 02:1702:17, 7 February 2012 diff hist 0 m Bevacizumab 1 revision current
- 02:1702:17, 7 February 2012 diff hist 0 m Bendamustine + Rituximab 1 revision current
- 02:1702:17, 7 February 2012 diff hist 0 m Bendamustine 1 revision current
- 02:1702:17, 7 February 2012 diff hist 0 m BFM B-Cell 1 revision current
- 02:1702:17, 7 February 2012 diff hist 0 m BFM- 95 (German Protocol) 1 revision current
- 02:1702:17, 7 February 2012 diff hist 0 m BEP 1 revision current
- 02:1702:17, 7 February 2012 diff hist 0 m Azacitidine 1 revision current
- 02:1702:17, 7 February 2012 diff hist 0 m Arsenic Trioxide for relapsed APML 1 revision current
- 02:1702:17, 7 February 2012 diff hist 0 m Arsenic Trioxide for APML, new cases 1 revision current
- 02:1702:17, 7 February 2012 diff hist 0 m Anal Carcinoma 1 revision current
- 02:1702:17, 7 February 2012 diff hist 0 m Amrubicin 1 revision current
- 02:1702:17, 7 February 2012 diff hist 0 m Alemtuzumab + Fludarabine 1 revision current
- 02:1702:17, 7 February 2012 diff hist 0 m Alemtuzumab 1 revision current
- 02:1702:17, 7 February 2012 diff hist 0 m Adriamycin + Cisplatin + Paclitaxel 1 revision current
- 02:1702:17, 7 February 2012 diff hist 0 m Adriamycin + Cisplatin 1 revision current
- 02:1702:17, 7 February 2012 diff hist 0 m Acute Myeloid Leukemia,Adult 1 revision
- 02:1702:17, 7 February 2012 diff hist 0 m Acute Lymphoblastic Leukemia, Pediatric 1 revision current
- 02:1702:17, 7 February 2012 diff hist 0 m Acute Lymphoblastic Leukemia, Adult 1 revision current
- 02:1702:17, 7 February 2012 diff hist 0 m ATRA plus As203 1 revision
- 02:1702:17, 7 February 2012 diff hist 0 m ASHAP 1 revision current
- 02:1702:17, 7 February 2012 diff hist 0 m AIDA-PETHEMA Group 1 revision current
- 02:1702:17, 7 February 2012 diff hist 0 m AI 1 revision current
- 02:1702:17, 7 February 2012 diff hist 0 m ADOC 1 revision current
- 02:1702:17, 7 February 2012 diff hist 0 m ADE 1 revision current
- 02:1702:17, 7 February 2012 diff hist 0 m AD 1 revision current
- 02:1702:17, 7 February 2012 diff hist 0 m AC 1 revision current
- 02:1702:17, 7 February 2012 diff hist 0 m ABVD 1 revision current
- 02:1702:17, 7 February 2012 diff hist 0 m ABDIC 1 revision current
- 02:1702:17, 7 February 2012 diff hist 0 m A-C-T 1 revision current
- 02:1702:17, 7 February 2012 diff hist 0 m 5-FU MitomycinC Radiation Therapy Wayne State Regimen 1 revision current
- 02:1702:17, 7 February 2012 diff hist 0 m 5-FU MitomycinC Radiation Therapy EORTC Regimen 1 revision current
- 02:1702:17, 7 February 2012 diff hist 0 m 5-FU + RT 1 revision current
- 02:1702:17, 7 February 2012 diff hist 0 m 5-FU + LV + RT 1 revision current
- 02:1702:17, 7 February 2012 diff hist 0 m 5-FU + LV + Mitomycin + Dipyridamole 1 revision current
- 02:1702:17, 7 February 2012 diff hist 0 m 5-FU + LV + Irinotecan 1 revision current
- 02:1702:17, 7 February 2012 diff hist 0 m 5-FU + LV + Bevacizumab 1 revision current
- 02:1702:17, 7 February 2012 diff hist 0 m 5-FU + LV 1 revision current
- 02:1702:17, 7 February 2012 diff hist 0 m 5-FU + Cisplatin + Vinblastine + RT + Surgery 1 revision current
- 02:1702:17, 7 February 2012 diff hist 0 m 5-FU + Cisplatin + RT + Surgery 1 revision current
- 02:1702:17, 7 February 2012 diff hist 0 m 5-FU + Cisplatin + RT 1 revision current
- 02:1702:17, 7 February 2012 diff hist 0 m 5-FU + Cisplatin + Docetaxel 1 revision current
- 02:1702:17, 7 February 2012 diff hist 0 m 5-FU + Cisplatin 1 revision current
- 02:1702:17, 7 February 2012 diff hist +162 Main Page →Getting started
28 November 2011
- 22:1722:17, 28 November 2011 diff hist +661 Nm Multiple Myeloma And Plasma Cell Dyscrasias →Bortezomib regimens
19 November 2011
- 01:4201:42, 19 November 2011 diff hist +1,539 N SMILE →References
19 September 2011
- 02:0902:09, 19 September 2011 diff hist +3,408 N Bonn protocol →References
15 September 2011
- 12:1412:14, 15 September 2011 diff hist +1,808 N Cyclophosphamide Bortezomib Dexamethasone New page: == Regimen == Bortezomib 1.3 mg/m(2) intravenously on days 1, 4, 8 and 11 Cyclophosphamide 300 mg/m(2) orally on days 1, 8, 15 and 22 Dexamethasone 40 mg orally on days 1-4, 9-12 and 1...
10 September 2011
- 23:4523:45, 10 September 2011 diff hist +2,924 Nm DT-PACE →Reference
7 September 2011
- 02:2802:28, 7 September 2011 diff hist +584 N Rituximab, Bendamustine, Bortezomib New page: ==Regimen== Bortezomib administered intravenously (IV) at a dose of 1.6 mg/m2 on days 1, 8, 15, and 22, cycles one to five; Bendamustine 50, 70, or 90 mg/m2 IV over a 60-minute infusio...
- 02:2302:23, 7 September 2011 diff hist +1,405 N Lymphoma Non-Hodgkin's, Adult →Indolent NHL
1 September 2011
- 04:4704:47, 1 September 2011 diff hist +3,968 N CFAR →References
- 04:4504:45, 1 September 2011 diff hist +834 N Chronic Lymphocytic Leukemia →Single agents
- 04:4304:43, 1 September 2011 diff hist +837 N Bendamustine →Indolent Non-Hodgkin's Lymphoma
13 July 2011
- 09:5509:55, 13 July 2011 diff hist +1,156 Nm BFM B-Cell →Block B
19 April 2011
- 05:5405:54, 19 April 2011 diff hist +699 N Clofarabine, cyclophosphamide and etoposide New page: == Regimen == Clofarabine 40 mg/m2 over 2 h IVI day 1-5 Cyclophosphamide 400 mg/m2 over 1 h day 1-5 Etooside 150 mg/m2 over 2 hr day 1-5 == Supportive == Prophylactic steroids were gi...
- 05:4505:45, 19 April 2011 diff hist +79 Nm Acute Lymphoblastic Leukemia, Pediatric →Relapse
5 April 2011
- 06:1706:17, 5 April 2011 diff hist +721 Nm Plerixafor and G-CSF →Regimen
- 06:1406:14, 5 April 2011 diff hist +169 N Stem Cell Transplantation →Mobilization Protocols
- 03:1403:14, 5 April 2011 diff hist +521 N GEM-Vinorelbine-Pred No edit summary
16 February 2011
- 03:1603:16, 16 February 2011 diff hist +2,063 N Main Page Editors added
29 December 2010
- 22:4522:45, 29 December 2010 diff hist +674 Nm Mitoxantrone + Prednisone Reverted edits by Emrick586899 (Talk); changed back to last version by Dobbs
13 December 2010
- 20:2320:23, 13 December 2010 diff hist +2,257 Nm Capecitabine Reverted edits by Alexander41972 (Talk); changed back to last version by Palmdoc
- 20:2120:21, 13 December 2010 diff hist +1,199 Nm Etoposide Reverted edits by Oswald569191 (Talk); changed back to last version by Palmdoc
22 July 2010
- 22:2822:28, 22 July 2010 diff hist +1,957 N BiRD →Reference
19 July 2010
- 07:4607:46, 19 July 2010 diff hist +1,954 Nm Bendamustine + Rituximab No edit summary
- 02:3902:39, 19 July 2010 diff hist +1,123 N PAD →Reference
- 02:2702:27, 19 July 2010 diff hist +1,402 N Alemtuzumab →[[Chronic_Lymphocytic_Leukemia|Chronic lymphocytic leukemia]]
3 May 2008
- 01:3901:39, 3 May 2008 diff hist +415 Nm Temozolomide + Thalidomide →Indication
5 December 2007
- 03:0303:03, 5 December 2007 diff hist +378 Nm Nasopharyngeal Cancer No edit summary
24 September 2007
- 13:5813:58, 24 September 2007 diff hist +770 N ABDIC No edit summary
- 10:3510:35, 24 September 2007 diff hist +481 N Lymphoma Hodgkin's, Adult No edit summary
7 September 2007
- 04:4304:43, 7 September 2007 diff hist +706 Nm GVD →Regimen
4 September 2007
- 08:3908:39, 4 September 2007 diff hist +3,932 N HyperCVADHDMTX-AraC →Hyper-CVAD
26 August 2007
- 23:1523:15, 26 August 2007 diff hist +10 N Test spam No edit summary
24 August 2007
- 23:3223:32, 24 August 2007 diff hist +546 Nm Guidelines for contributors No edit summary
17 August 2007
- 21:4121:41, 17 August 2007 diff hist +587 Nm TIP →Indication
- 09:0009:00, 17 August 2007 diff hist +2,599 Nm 5-FU + LV →Hepatocellular Carcinoma
15 August 2007
- 08:2208:22, 15 August 2007 diff hist +1,587 N CODOX-M/IVAC →[[Lymphoma_Non-Hodgkin%27s%2C_Adult|Non-Hodgkin's Lymphoma]]
10 August 2007
- 01:5901:59, 10 August 2007 diff hist +1,119 Nm Decitabine →Myelodysplastic syndrome
- 01:5801:58, 10 August 2007 diff hist +1,081 Nm Carmustine →Indications
- 01:5701:57, 10 August 2007 diff hist +1,772 Nm Bortezomib →[Lymphoma_Non-Hodgkin%27s%2C_Adult#Mantle_Cell_Lymphoma|Mantle Cell Lymphoma]]
- 01:5501:55, 10 August 2007 diff hist +1,275 Nm Azacitidine →Indications
9 August 2007
- 07:1307:13, 9 August 2007 diff hist +1,307 Nm Breast Cancer →Chemotherapy
- 03:3203:32, 9 August 2007 diff hist +446 Nm Endometrial Cancer No edit summary
- 03:2203:22, 9 August 2007 diff hist +1,244 Nm 5-FU + Cisplatin →Esophageal Cancer
- 03:1703:17, 9 August 2007 diff hist +1,635 Nm R-CHOP →Regimen
- 03:1503:15, 9 August 2007 diff hist +231 Nm Hairy Cell Leukemia →Single agent
- 03:1203:12, 9 August 2007 diff hist +2,824 N Cladribine No edit summary
- 03:0903:09, 9 August 2007 diff hist +1,359 Nm Fludarabine →[[Chronic_Lymphocytic_Leukemia|Chronic Lymphocytic Leukemia]]
8 August 2007
- 06:0706:07, 8 August 2007 diff hist +1,689 Nm PCV →References
- 05:5705:57, 8 August 2007 diff hist +429 Nm Temozolomide + RT →Anaplastic astrocytoma and glioblastoma
- 01:4201:42, 8 August 2007 diff hist +1,565 Nm Rituximab →Indications
- 01:2701:27, 8 August 2007 diff hist +576 Nm Cytotoxic Regimens →External Links
- 01:2401:24, 8 August 2007 diff hist +483 Nm Cyclophosphamide →[Lymphoma_Non-Hodgkin%27s%2C_Adult#Indolent_NHL|Indolent NHL]]
- 01:2201:22, 8 August 2007 diff hist +164 Nm Cancer treatment information No edit summary
7 August 2007
- 23:0923:09, 7 August 2007 diff hist +552 Nm Brain Tumors Adult No edit summary
- 06:4306:43, 7 August 2007 diff hist +721 N Gemcitabine + Cisplatin + Paclitaxel New page: == Indication == locally advanced or metatstatic bladder cancer *Gemcitabine (Gemzar) 1000 mg/m2 iv over 30-60 min d1, 8 *Cisplatin 70 mg/m2 iv d1 *Paclitaxel (Taxol) 80 mg/m2 iv d1, 8 Q3...
- 06:4106:41, 7 August 2007 diff hist +436 N Gemcitabine + Paclitaxel New page: == Indication == metastatic bladder cancer *Gemcitabine (Gemzar) 1000 mg/m2 iv d1, 8 and 15 *Paclitaxel (Taxol) 200 mg/m2 iv over 3 hrs d1 Q3w x 6 cycles === References === [http://www....
- 05:5105:51, 7 August 2007 diff hist +595 N LV5FU-P New page: == Regimen == *Leucovorin 200 mg/m2 iv over 2 hrs d1 *5-FU 400 mg/m2 iv bolus, followed by 600 mg/m2 iv over 22 hrs, d1 and 2 *Cisplatin 50 mg/m2 iv d2 Q2w == References == [http://annonc...
- 04:0304:03, 7 August 2007 diff hist +653 Nm Pentostatin No edit summary
- 03:2303:23, 7 August 2007 diff hist +2,597 Nm Imatinib No edit summary
